Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rossella Bitonti

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
BMC Health Services Research|April 28, 2022
Cost-effectiveness analysis of brolucizumab versus aflibercept for the treatment of neovascular age-related macular degeneration (nAMD) in ItalyNicola Ferrante, Daniela Ritrovato, Rossella Bitonti, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|September 11, 2020
Using 2nd generation basal insulins in type 2 diabetes: Costs and savings in a comparative economic analysis in Italy, based on the BRIGHT studyRaffaele Napoli, Francesca Fanelli, Luca Gazzi, et al.
Global & Regional Health Technology Assessment|January 11, 2023
Antonio Costanzo, Gianluca Furneri, Rossella Bitonti, et al.
Journal of Personalized Medicine|June 24, 2022
Cost-Utility Analysis of Dupilumab for the Treatment of Chronic Rhinosinusitis with Nasal Polyps (CRSwNP) in ItalyEugenio De Corso, Gianluca Furneri, Daria Salsi, et al.
BMC Health Services Research|September 8, 2018
How has the cost of antiretroviral therapy changed over the years? A database analysis in ItalyLucia Taramasso, Federica Demma, Rossella Bitonti, et al.
The World Allergy Organization Journal|August 19, 2024
Type 2 asthma paediatric patients eligible for dupilumab: An Italian biomarker-based analysisGiorgio Piacentini, Alessandro Fiocchi, Gianluigi Marseglia, et al.
Health Economics Review|November 26, 2025
Horizon scanning and drug expenditure for rare diseases: three-year predictive model in Italy 2025-2027Andrea Marcellusi, Daniela Cazzato, Giulio Guarnotta, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
BMC Health Services Research|April 28, 2022
Cost-effectiveness analysis of brolucizumab versus aflibercept for the treatment of neovascular age-related macular degeneration (nAMD) in ItalyNicola Ferrante, Daniela Ritrovato, Rossella Bitonti, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|September 11, 2020
Using 2nd generation basal insulins in type 2 diabetes: Costs and savings in a comparative economic analysis in Italy, based on the BRIGHT studyRaffaele Napoli, Francesca Fanelli, Luca Gazzi, et al.
Global & Regional Health Technology Assessment|January 11, 2023
Antonio Costanzo, Gianluca Furneri, Rossella Bitonti, et al.
Journal of Personalized Medicine|June 24, 2022
Cost-Utility Analysis of Dupilumab for the Treatment of Chronic Rhinosinusitis with Nasal Polyps (CRSwNP) in ItalyEugenio De Corso, Gianluca Furneri, Daria Salsi, et al.
BMC Health Services Research|September 8, 2018
How has the cost of antiretroviral therapy changed over the years? A database analysis in ItalyLucia Taramasso, Federica Demma, Rossella Bitonti, et al.
The World Allergy Organization Journal|August 19, 2024
Type 2 asthma paediatric patients eligible for dupilumab: An Italian biomarker-based analysisGiorgio Piacentini, Alessandro Fiocchi, Gianluigi Marseglia, et al.
Health Economics Review|November 26, 2025
Horizon scanning and drug expenditure for rare diseases: three-year predictive model in Italy 2025-2027Andrea Marcellusi, Daniela Cazzato, Giulio Guarnotta, et al.
Pageof 1